Navigation Links
Hormone Therapy May Cut Colorectal Cancer Risk
Date:1/8/2009

Study included nearly 57,000 women who had been followed for about 15 years

THURSDAY, Jan. 8 (HealthDay News) -- Hormone therapy may lower a woman's risk of colorectal cancer, especially if she is no longer taking the hormones.

This new finding, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, further complicates an already murky picture of the risks and benefits of hormone replacement therapy (HRT).

Previous landmark research has shown an increased risk of breast cancer and cardiovascular problems, but a lowered risk of colon cancer. More recent studies have found that the stage in life when a woman takes hormone therapy can influence the effect. The drugs are typically prescribed to women dealing with menopausal symptoms.

Other studies have also found a lowered risk of colon cancer among HRT users and, at this time, the weight of the evidence seems to point in that direction.

"These data do add additional weight to prior reports suggesting that hormone replacement therapy reduces the risk of colorectal cancer," said Dr. Neal Meropol, director of the Gastrointestinal Cancer Program at Fox Chase Cancer Center in Philadelphia.

But the studies have yet to translate into discoveries that can affect medical practice.

"This study highlights the complexity of systems that affect tumor development and growth, and raises the possibility that there will be pathways we can identify that can be specifically targeted that can be used to prevent and treat colon cancer," Meropol added. "These findings open the door to asking other fundamental questions about what causes colon cancers to develop, the results of which could provide clues to new prevention strategies."

The new study, led by researchers at the University of Minnesota School of Public Health, gleaned information on colorectal cancer incidence and hormone use from nearly 57,000 women who had been followed for about 15 years.

The researchers found a 17 percent reduced risk of colorectal cancer among women who had ever used estrogen alone, a 25 percent reduced risk among women currently using estrogen, and a 26 percent reduced risk among those using estrogen for 10 or more years.

Among women taking estrogen plus progestin, there was a 22 percent reduced risk, and a 45 percent reduced risk -- the highest seen -- among those who had stopped taking the combination hormones at least five years earlier.

The researchers also reported a 36 percent drop in risk among women who'd used progestin sequentially -- less than 15 days a month.

It's not clear what the biological mechanisms might be that could contribute to the reduction in risk.

"It appears that estrogens likely have direct or indirect effects on the growth of colonic epithelial cells," Meropol said.

More information

The Women's Health Initiative has more on the health effects of HRT in postmenopausal women.



SOURCES: Neal Meropol, M.D., director, Gastrointestinal Cancer Program, Fox Chase Cancer Center, Philadelphia; January 2009 Cancer Epidemiology, Biomarkers and Prevention


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Drop in breast cancer incidence linked to hormone use, not mammograms
2. Researchers develop long-lasting growth hormone
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
5. Most Women Unaware of Hormone Replacement Study
6. Survival data presented from phase II study of hormone-resistant prostate cancer patients
7. Hormone May Play Key Part in Creating Memories
8. Hormone Therapy for Prostate Cancer Linked to Heart Risks
9. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
10. New data on hormone therapy must lead to re-evaluation of official guidelines
11. From Hot Flashes to Breast Cancer: ZRT Labs Hormone Testing Catches On As Women Consider Safer, More Natural Options.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
(Date:6/24/2016)... ... , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event ... that have been wounded in battle and their families. Venture Construction Group is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: